Israel Chemicals (ICL) Posts Quarterly Earnings Results

Israel Chemicals (NYSE:ICL) released its quarterly earnings data on Wednesday. The basic materials company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.08 by $0.03, Morningstar.com reports. Israel Chemicals had a net margin of 4.47% and a return on equity of 13.20%. The business had revenue of $1.36 billion during the quarter. During the same period last year, the company earned $0.09 EPS. The firm’s revenue for the quarter was up 1.7% on a year-over-year basis.

Shares of Israel Chemicals (NYSE ICL) traded up $0.17 during trading hours on Wednesday, hitting $4.13. 212,091 shares of the company were exchanged, compared to its average volume of 369,167. The company has a current ratio of 1.24, a quick ratio of 0.70 and a debt-to-equity ratio of 0.93. Israel Chemicals has a 1 year low of $3.85 and a 1 year high of $4.95. The company has a market cap of $5,049.86, a P/E ratio of 14.14 and a beta of 1.16.

Several large investors have recently made changes to their positions in the stock. Renaissance Technologies LLC lifted its holdings in shares of Israel Chemicals by 82.2% in the 4th quarter. Renaissance Technologies LLC now owns 841,700 shares of the basic materials company’s stock valued at $3,400,000 after acquiring an additional 379,800 shares during the last quarter. Amundi Pioneer Asset Management Inc. bought a new position in shares of Israel Chemicals in the 4th quarter valued at about $171,000. Geode Capital Management LLC bought a new position in shares of Israel Chemicals in the 4th quarter valued at about $182,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Israel Chemicals by 65.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 3,065,779 shares of the basic materials company’s stock valued at $12,421,000 after acquiring an additional 1,209,368 shares during the last quarter. Finally, BlackRock Inc. lifted its holdings in shares of Israel Chemicals by 37.9% in the 4th quarter. BlackRock Inc. now owns 100,051 shares of the basic materials company’s stock valued at $404,000 after acquiring an additional 27,472 shares during the last quarter. 6.31% of the stock is owned by hedge funds and other institutional investors.

Several research firms have commented on ICL. Zacks Investment Research raised shares of Israel Chemicals from a “sell” rating to a “hold” rating in a report on Thursday, February 1st. ValuEngine raised shares of Israel Chemicals from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Israel Chemicals currently has a consensus rating of “Hold” and an average target price of $4.88.

WARNING: This news story was first reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/14/israel-chemicals-icl-posts-quarterly-earnings-results.html.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash and salt from subterranean mines in Spain and the United Kingdom, as well as uses part of the potash to produce compound fertilizers; mines and processes phosphate rock in open mines; and produces sulfuric acid, agricultural phosphoric acid, phosphate fertilizers, compound fertilizers, liquid fertilizers, and soluble fertilizers.

Earnings History for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply